Statement Of Cash Flows [Abstract]

PureTech Health plc - Filing #5879297

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
25,728,000 USD
27,782,000 USD
53,510,000 USD
53,510,000 USD
66,628,000 USD
931,000 USD
65,697,000 USD
65,697,000 USD
50,354,000 USD
37,065,000 USD
50,354,000 USD
13,290,000 USD
Adjustments to reconcile profit (loss) [abstract]
Adjustments for income tax expense
4,008,000 USD
30,525,000 USD
55,719,000 USD
Adjustments for increase (decrease) in trade accounts payable
9,695,000 USD
3,844,000 USD
22,033,000 USD
Adjustments for depreciation and amortisation expense
3,571,000 USD
4,933,000 USD
8,893,000 USD
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss
226,000 USD
1,260,000 USD
USD
Adjustments for share-based payments
22,850,000 USD
4,415,000 USD
14,698,000 USD
Adjustments for fair value losses (gains)
2,398,000 USD
77,945,000 USD
32,060,000 USD
Adjustments for losses (gains) on disposal of non-current assets
151,000 USD
265,000 USD
29,303,000 USD
Interest paid, classified as operating activities
1,295,000 USD
1,701,000 USD
3,366,000 USD
Interest received, classified as operating activities
23,547,000 USD
14,454,000 USD
3,460,000 USD
Income taxes paid (refund), classified as operating activities
37,913,000 USD
150,000 USD
20,696,000 USD
Other inflows (outflows) of cash, classified as operating activities
92,000 USD
1,374,000 USD
359,000 USD
Cash flows from (used in) operating activities
134,369,000 USD
105,917,000 USD
178,792,000 USD
Cash flows from (used in) investing activities [abstract]
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities
298,109,000 USD
33,309,000 USD
118,710,000 USD
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
USD
USD
5,000,000 USD
Proceeds from sales of property, plant and equipment, classified as investing activities
255,000 USD
865,000 USD
USD
Purchase of property, plant and equipment, classified as investing activities
11,000 USD
70,000 USD
2,176,000 USD
Purchase of intangible assets, classified as investing activities
USD
175,000 USD
USD
Cash flows from (used in) investing activities
240,888,000 USD
68,991,000 USD
107,223,000 USD
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
3,394,000 USD
3,338,000 USD
4,025,000 USD
Other inflows (outflows) of cash, classified as financing activities
USD
23,000 USD
41,000 USD
Cash flows from (used in) financing activities
16,958,000 USD
78,141,000 USD
29,827,000 USD
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
89,560,000 USD
41,215,000 USD
315,842,000 USD
Cash and cash equivalents
280,641,000 USD
191,081,000 USD
149,866,000 USD
465,708,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.